Merck & Co., Inc. (MRK) operating KPIs
MRKNYSEPharmaceutical PreparationsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 7, 2026Score 9/30242% above fair value
$146.33+5.40 (+3.83%)
Close on Oct 29, 2026Market cap $361.02BP/E 117.1Yield 2.24%
Merck new Hires — Eastern Europe, Middle East & Africa (headcount)
Merck Impact Report
Latest, FY2025
150
Period ended Dec 31, 2025
Change on a year earlier
-22.7%
194 in FY2024
History
5 years
Since FY2021
Sources
1
Documents cited below
Annual history
Hover a value to see the sentence it was read from; calculated values show their formula
| Period | Ended | New Hires — Eastern Europe, Middle East & Africa (headcount) | Year on year | Source |
|---|---|---|---|---|
| FY2025 | Dec 31, 2025 | 150 | -22.7% | – |
| FY2024 | Dec 31, 2024 | 194 | -34.2% | – |
| FY2023 | Dec 31, 2023 | 295 | 0.0% | – |
| FY2022 | Dec 31, 2022 | 295 | -20.9% | – |
| FY2021 | Dec 31, 2021 | 373 | – | – |
Cite this data
StockData. (2026). Merck New Hires — Eastern Europe, Middle East & Africa (headcount), annual FY2021–FY2025 [Data set]. Compiled from Merck SEC filings and investor materials. https://stockdatahq.com/stocks/mrk/kpis/hr_hires_eemea
See every metric in the Merck KPI table. Data updated Oct 26, 2026.